MRI Vessel Wall Imaging — Intracranial Arteries (Dedicated Protocol)

MRI Vessel Wall Imaging — Intracranial Arteries (Dedicated Protocol)

MRIninja Knowledge Base | Child Protocol Page Parent page: MRI Vessel Wall Imaging — Universal Technique Master Version 1.1 — September 2026

1. Executive Summary

This page covers the intracranial arterial territory specifically — the Circle of Willis and its major branches — as one of several vascular territories to which the vessel wall imaging (VWI) technique is applied. The shared, territory-independent physics (black-blood preparation mechanisms, the multi-contrast plaque-characterisation principle, the rationale for direct wall visualisation over lumen-only imaging) is developed once, in full, on the parent Universal Technique Master page and is not repeated here. This page assumes that shared foundation as already known and focuses exclusively on what is specific to the intracranial territory: anatomy, coverage requirements, positioning, typical parameters, and the disease-specific diagnostic framework (ICAD, vasculitis, dissection, RCVS, aneurysm wall) that dominates intracranial VWI's clinical use.

Intracranial VWI has transformed the non-invasive evaluation of intracranial arteriopathies. Since its systematic clinical introduction in the early 2010s, and following the 2017 American Society of Neuroradiology (ASNR) VWI consensus statement [1] — the intracranial-territory-specific consensus, distinct from the carotid- and aortic-specific literature summarised on the parent page — it has become the reference standard for characterising the cause of unexplained ischaemic stroke (particularly in young patients and in cryptogenic stroke), for distinguishing vasospasm from intracranial atherosclerotic disease (ICAD) from reversible cerebral vasoconstriction syndrome (RCVS), and for characterising intracranial aneurysm wall inflammation prior to rupture risk assessment.

Disease-specific child pages of this territory page (ICAD, vasculitis, dissection, aneurysm wall, RCVS) should treat both this page and the parent Universal Technique Master as already established and focus exclusively on disease-specific modifications and findings.

1.1 Core Strengths

Direct wall visualisation: VWI is the only non-invasive imaging modality that directly images the arterial wall in cross-section, characterising its thickness, signal, and enhancement pattern. This allows distinction between wall pathologies that are indistinguishable on lumen-based imaging.

Differentiating causes of intracranial stenosis: the single most important VWI application. Focal ICAD produces eccentric plaque with positive remodelling, lipid core, and enhancement. Intracranial vasculitis produces concentric, smooth wall thickening with uniform enhancement. RCVS produces no wall thickening and no enhancement. Vasospasm (e.g., after SAH) produces no intrinsic wall signal change. These distinctions are impossible on MRA alone and have direct therapeutic implications [1,2].

Aneurysm wall characterisation: gadolinium-enhancing aneurysm wall segments and surrounding perianeurysmal enhancement (PAE) correlate with wall inflammation, unstable aneurysm biology, and rupture risk — independent of size. VWI provides pre-treatment risk stratification information beyond morphological criteria [1,3].

Intracranial dissection diagnosis: VWI directly demonstrates the intramural haematoma (T1-bright crescent) within the dissected wall, the intimal flap, and the double lumen — findings that conventional MRI and MRA may miss or undercharacterise in intracranial dissections.

Cryptogenic stroke evaluation: in stroke with negative conventional workup (normal echo, ECG, coagulation, no AF), intracranial VWI detects previously invisible causes — enhancing ICAD plaque, focal vasculitis, dissection, or moyamoya vasculopathy — in a significant proportion of patients, redirecting management [1].

1.2 Intrinsic Limitations of the Generic Protocol

Resolution vs coverage trade-off: high in-plane resolution (≤ 0.5 mm) and thin slices (≤ 0.8 mm) require long acquisition times (5–10 minutes per 3D volume). Achieving whole-brain intracranial arterial coverage at true sub-millimetre isotropic resolution at 3T is at the edge of clinical feasibility. Targeted acquisitions (single vessel or limited segment) at maximum resolution are often more clinically valuable than whole-brain coverage at lower resolution.

3T minimum, 7T preferred for small vessels: the wall of normal intracranial arteries is 0.2–0.5 mm thick. Reliable wall visualisation requires in-plane resolution ≤ 0.5 mm. This is achievable at 3T with dedicated surface coils and advanced sequences but approaches the SNR limit. At 1.5T, VWI is technically feasible only for the largest intracranial arteries (MCA M1, basilar artery) and is considered substandard for routine clinical use.

Flow suppression completeness: black-blood imaging relies on complete suppression of moving blood signal. Slow flow (in aneurysm sacs, in heavily stenotic segments, in dural venous sinuses) may not be fully suppressed, producing residual intraluminal signal that could be misidentified as wall thickening or plaque.

When dedicated child protocols are required: intracranial atherosclerotic disease (ICAD) characterisation and plaque assessment; intracranial vasculitis (primary or secondary); intracranial dissection; intracranial aneurysm wall imaging pre-treatment; RCVS vs vasospasm vs vasculitis; moyamoya vasculopathy progression; cervical artery dissection (extracranial); coronary and aortic VWI (body protocols).

2. Main Clinical Indications

2.1 Standard Indications

Cryptogenic ischaemic stroke in young patients is the leading indication for intracranial VWI in clinical practice. When conventional work-up is negative, VWI detects underlying intracranial arteriopathy — including non-stenotic ICAD plaque, focal vasculitis, dissection, or moyamoya — in a substantial proportion of cases with a focal neurological deficit and no identified embolic source [1]. The generic VWI protocol is appropriate as the initial assessment.

Characterisation of intracranial stenosis — when MRA demonstrates an intracranial stenosis, VWI provides the critical pathological characterisation that directs treatment: eccentric plaque with positive remodelling (ICAD → antiplatelet, statin, risk factor control); concentric smooth thickening with enhancement (vasculitis → immunosuppression); no wall thickening, no enhancement (RCVS, vasospasm → calcium channel blocker, avoid triggers). The management implications of this distinction make VWI the standard of care for symptomatic intracranial stenosis evaluation [1].

Intracranial aneurysm risk stratification — for aneurysms managed conservatively (observation), VWI provides supplementary risk information. Aneurysm wall enhancement (AWE) and perianeurysmal enhancement are associated with symptomatic aneurysms and may identify unstable lesions not predicted by size alone. This is particularly relevant for medium-sized aneurysms (5–10 mm) where the size criterion is insufficient for treatment decisions [3].

Suspected intracranial vasculitis (primary CNS angiitis, secondary vasculitis in SLE, sarcoid, infection) — VWI confirms the diagnosis (concentric smooth enhancement), assesses distribution (multifocal vs unifocal), guides biopsy site selection, and monitors treatment response.

Intracranial dissection — VWI demonstrates the intramural haematoma directly (T1-bright eccentric crescent within the wall), distinguishing dissection from other causes of irregular vessel contour. Particularly important for vertebral and basilar artery dissections where conventional MRI sequences may be non-diagnostic.

Subarachnoid haemorrhage (SAH) — vessel wall assessment: in the post-SAH period, VWI differentiates cerebral vasospasm (no wall signal change) from inflammatory arteriopathy, and evaluates the culprit aneurysm wall for signs of instability.

2.2 Urgent Red Flags

3. Preparation Reference

Universal MRI safety screening belongs to the general MRI preparation page and is not repeated here.

3.1 Anatomy-Specific Preparation Items

Gadolinium is required for most VWI indications: the detection of wall enhancement is the primary diagnostic feature distinguishing active vasculitis, vulnerable ICAD plaque, and unstable aneurysm wall from quiescent lesions. Standard dose gadolinium (0.1 mmol/kg) is used. Macrocyclic GBCA are preferred per MRIninja protocol standard.

High-resolution head coil is mandatory: a 20–32 channel head coil provides the SNR necessary for sub-millimetre wall imaging. Surface coils (small loop coils positioned near the target artery) provide the highest SNR for targeted single-vessel VWI but require more operator expertise for positioning.

Prior imaging review: VWI should always be interpreted in conjunction with prior MRA (CTA or MR), DWI, and any prior VWI. The topographical relationship between a VWI-positive wall lesion and the ischaemic DWI lesion (the "culprit lesion" concept) is the most important interpretive step for stroke evaluation.

Metal near the head: as for all brain MRI; dental metalwork produces susceptibility artefacts that can affect VWI of the MCA at 3T. Document and note in report.

3.2 Patient Positioning on the MRI System

Position: supine, head-first. Standard 20–32 channel head coil. Identical to standard brain MRI.

Isocentre: at the level of the Circle of Willis — approximately at the level of the nasion or the external auditory canal level. This positions the primary intracranial arterial targets at the B0 field centre, optimising shimming and fat suppression quality for the VWI sequences. This differs slightly from the standard brain MRI isocentre (which is at midface to cover the brain from vertex to brainstem); for VWI, slightly inferior isocentre centred on the skull base/Circle of Willis is preferred.

Head symmetry and immobilisation: VWI at sub-millimetre resolution over 5–10 minutes is highly motion-sensitive. Head immobilisation foam should be applied firmly. Patient co-operation instructions: the acquisition is long; any head movement will degrade the submillimetre resolution. Consider sedation for patients with movement disorders.

4. Standard Protocol Design

VWI is organised around a black-blood 3D high-resolution structural sequence as the primary, technique-defining acquisition. This section deliberately separates that VWI-specific core from the generic brain sequences (T2, DWI/ADC, FLAIR) that are frequently acquired in the same session — because the leading clinical indication for intracranial VWI is stroke work-up — but that are not themselves vessel wall imaging sequences. Conflating the two is a common, avoidable source of protocol confusion (Section 8.4), which is why the distinction is made explicit here rather than left implicit in a single combined table.

4.1 Mandatory Core VWI Sequences — What Actually Constitutes Vessel Wall Imaging

Only the following three sequences are intrinsic to vessel wall imaging as a technique. Together, they are sufficient to answer the core VWI question — is there wall pathology, and does it enhance — independent of whatever broader clinical context motivated the examination:

4.2 Companion Brain-Protocol Sequences — Not VWI Sequences, but Frequently Co-Acquired

DWI/ADC, T2-weighted brain, and FLAIR are not vessel wall imaging sequences. They are standard components of the generic Brain MRI protocol, included in an intracranial VWI session specifically because the leading clinical indication for intracranial VWI — cryptogenic stroke work-up (Section 2.1) — requires them for an entirely separate reason: identifying the ischaemic territory and supporting the "culprit lesion" concept (Section 7.1), which correlates a VWI-positive wall segment with the DWI-positive downstream territory. When intracranial VWI is performed for a different indication where this correlation is not relevant (for example, an isolated aneurysm-wall-enhancement question with no stroke component), these three sequences are not required by the VWI technique itself and may reasonably be omitted or abbreviated, at the requesting clinician's discretion.

4.3 Conditional VWI-Specific Sequences

4.4 Rationale Summary Per Sequence

3D T1 Black-Blood (Pre- and Post-Contrast) — The Defining Sequence

The black-blood mechanism: in conventional MRI, flowing blood appears either bright (TOF effect in GRE sequences) or dark (flow void in SE/TSE sequences at fast flow, T1-dark at long TE). Black-blood VWI requires complete suppression of the intraluminal blood signal — both fast-flowing blood and slow/recirculating blood — while preserving the wall signal. This is achieved through a combination of mechanisms:

Double Inversion Recovery (DIR): a global non-selective 180° inversion pulse followed immediately by a slice-selective 180° re-inversion pulse. The first pulse inverts all magnetisation (brain + blood). The second pulse re-inverts only the slice-of-interest tissue, restoring it to +Mz. Blood flowing through the imaging slice during the inversion time (TI) is fully inverted but not re-inverted — it arrives at the TI null point with zero Mz → black blood. This is the classic black-blood preparation that works well for in-plane flow (e.g., carotid artery in the neck).

Motion Sensitised Driven Equilibrium (MSDE): a preparation module that applies a diffusion-like bipolar gradient sensitised to the motion of flowing blood, driving flowing spins to zero transverse magnetisation through velocity-dependent dephasing. Unlike DIR, MSDE is effective for all flow directions and is therefore preferred for intracranial VWI where arteries run in multiple directions. MSDE does not require TI timing calibration for a specific blood velocity.

3D volume-selective inversion (for 3D acquisitions): a slab-selective pre-saturation or inversion applied to the imaging volume with a delay that allows blood to wash out and be replaced by fully saturated (or inverted-to-null) blood from outside the slab. Combined with MSDE, this produces the most complete black-blood suppression.

The standard clinical VWI sequence is a 3D black-blood T1-weighted TSE (variable flip angle TSE with MSDE or DIR preparation). Published implementations include VISTA-BB (Philips), SPACE with black-blood preparation (Siemens), CUBE BB (GE), and T1 SNAP (Siemens — Simultaneous Non-contrast Angiography and intraPlaque hemorrhage).

Wall signal on T1 black-blood: normal wall — thin, isointense to brain parenchyma, no enhancement; ICAD plaque — eccentric thickening, T1-bright core (lipid, haemorrhage), positive remodelling (outer diameter maintained or increased despite plaque); vasculitis — concentric smooth thickening, mild T1 signal, uniform enhancement; intramural haematoma (dissection) — T1-bright eccentric crescent within the wall; aneurysm wall — thin regular wall suggests low rupture risk, thick/irregular/enhancing wall suggests potential instability.

Pre-contrast and Post-contrast: Both Are Mandatory and Must Match

The subtraction principle (post minus pre T1 black-blood) is the primary method for identifying true wall enhancement. Without a matched pre-contrast acquisition, T1-bright pre-existing wall signal (intramural haematoma, calcification, lipid core) cannot be distinguished from true gadolinium enhancement — both appear bright on post-contrast T1.

The pre-contrast and post-contrast 3D black-blood volumes must use identical geometry (same FOV, same voxel size, same slice positions). Any geometric mismatch prevents reliable subtraction. Automated subtraction (post minus pre T1 black-blood) is performed on the matched volumes and provides a direct enhancement map.

3D TOF MRA — The Lumen Reference

VWI wall imaging must always be interpreted in conjunction with the luminal assessment from 3D TOF MRA (or contrast-enhanced MRA). The TOF lumen reference provides: the degree of stenosis at the VWI-positive segment; the topography of the stenosis within the vessel; the reference for identifying which arterial segment corresponds to the VWI finding; and evidence of occlusion or collateral flow. Without a lumen reference, VWI findings cannot be localised with precision.

DWI — The Stroke Lesion Map

For stroke VWI, DWI is mandatory to identify the ischaemic territory and to confirm the "culprit lesion" concept: a VWI-positive wall segment (enhancing plaque, vasculitis, dissection) in the artery perfusing the DWI-positive territory is the likely stroke cause. A VWI-positive finding in a vessel remote from the DWI lesion is less likely to be the stroke cause.

4.5 Sequence Matching and Cross-Sequence Consistency

Pre- and post-contrast black-blood T1 must use identical geometry: this is the most critical matching requirement in VWI. Register pre-contrast to post-contrast images before subtraction (automated deformable registration is preferred, as head position may shift slightly between acquisitions). Verify registration quality at the wall level — even 0.3 mm misregistration produces subtraction artefacts that simulate wall enhancement.

VWI and TOF MRA registration: the VWI volume and the TOF MRA must be co-registered for the topographic "culprit lesion" analysis. Most workstations support overlay of VWI on a transparent MRA MIP.

Serial VWI for treatment monitoring: for vasculitis treatment monitoring, identical acquisition parameters (field strength, 3D black-blood sequence, voxel size, gadolinium dose and timing) must be reproduced. Wall thickness measurements and enhancement grade changes are the primary metrics for treatment response.

4.6 Fat Suppression

Fat suppression is not routinely applied to the primary 3D black-blood VWI sequence. The signal suppression achieved by the black-blood preparation and the T1 weighting of the sequence is sufficient to distinguish the wall from surrounding structures in the intracranial compartment, which contains no fat.

Exception: for extracranial vessel wall imaging (carotid or vertebral artery dissection in the neck), fat suppression on the T1 axial sequences is required — the intramural haematoma must be identified against the background of surrounding cervical fat. Fat-saturated T1 axial (STIR or SPAIR) of the neck is standard for extracranial dissection, separate from the intracranial black-blood protocol.

Post-contrast STIR is absolutely contraindicated as throughout all MRIninja protocols.

4.7 Slice Positioning — Complete Technical Reference

Why Precise Positioning Is Critical for VWI

The intracranial arteries are small (normal MCA diameter: 2.5–4 mm; normal basilar artery: 2.5–4.5 mm; normal MCA wall thickness: 0.2–0.5 mm). At 0.5 mm isotropic voxels, an artery of 3 mm outer diameter spans 6 voxels. The wall (0.3 mm thick) spans less than 1 voxel in the wall-perpendicular direction. Accurate positioning that places the artery at the optimal in-plane orientation is essential for minimising partial volume averaging of the wall with luminal blood signal and with perivascular CSF.

Anatomical Targets and Their Imaging Requirements

The Circle of Willis and its major branches are the primary intracranial VWI targets:

Because arteries run in multiple directions, isotropic 3D acquisition is the standard approach — the isotropic dataset is reformatted post-acquisition in the plane perpendicular to the vessel at any segment of interest. This is the single most important technical reason for 3D isotropic (not 2D multi-slice) VWI acquisition.

Coverage for Standard Intracranial VWI

The standard 3D isotropic black-blood volume must cover: superior boundary — above the A2/A3 ACA segments and the top of the MCA; inferior boundary — below the vertebral artery V4 segments and the basilar artery origin; lateral boundaries — bilateral MCA M2/M3 segments within the Sylvian fissures; anterior — the cavernous and supraclinoid ICA bilaterally; posterior — the entire basilar artery and bilateral PCA P1/P2. This typically requires a slab of approximately 70–100 mm in the axial dimension, 180–200 mm in the coronal, and 200–220 mm in the sagittal — acquired as a 3D isotropic volume.

Axial Planning

Reference: standard brain axial plane parallel to the AC-PC line. This is the standard orientation for all brain sequences and is appropriate for VWI.

Phase encoding direction: A-P for axial acquisitions — see the platform's Fold-over Direction parameter deep dive for the general principles governing this choice. This is standard for brain MRI and minimises flow/pulsation artefacts from the basilar artery (displacing any residual pulsation artefact anteroposteriorly, away from the posterior fossa structures).

Verify Circle of Willis coverage on the sagittal localiser: the entire Circle of Willis from the cavernous ICA (inferiorly) to the A2/P2 segments (superiorly) must be within the 3D slab. Plan the inferior boundary below the carotid siphon and the superior boundary above the MCA bifurcation.

Post-Acquisition Reformatting

The isotropic 3D black-blood volume enables reformatting in any plane post-acquisition. Standard reformats: cross-sectional (perpendicular to vessel axis) — the primary diagnostic reformat, giving the true cross-sectional wall profile, enabling wall thickness measurement, and showing plaque eccentricity; longitudinal (along vessel axis) — curved multi-planar reformat along the vessel trajectory, showing the longitudinal extent of wall thickening or enhancement; overlay on TOF MRA MIP — co-registers the VWI findings topographically on the lumen reference image.

Targeted High-Resolution Acquisition

For single-vessel targeting (e.g., a single basilar artery atherosclerotic plaque, or a specific aneurysm neck): reduced FOV (100–150 mm); higher resolution (0.3–0.4 mm isotropic); higher NSA (2–4); acquisition time 8–12 minutes per targeted volume. This targeted approach provides wall characterisation at the limit of clinical MRI resolution but at the cost of coverage.

5. Optimisation Strategy

5.1 Artefact Reduction by Source

Incomplete blood signal suppression — the primary VWI quality problem

In-plane flow (blood flowing within the imaging plane rather than through it) is suppressed less efficiently by DIR-based black-blood preparations than through-plane flow. For tortuous arteries or for arteries running horizontally (parallel to the axial slice), residual intraluminal signal appears as T1-bright content that simulates intramural haematoma or plaque.

• Physical cause: DIR relies on blood flowing out of the imaging slice before the readout — in-plane flow does not exit the slice
• Appearance: bright crescent within the vessel lumen mimicking mural thrombus or intramural haematoma
• Reduction: MSDE preparation (velocity-sensitive dephasing in all directions, independent of flow direction); 3D volume inversion preparation; use of isotropic 3D acquisition that allows perpendicular reformatting to identify in-plane flow as luminal rather than mural
• When invalidating: extensive residual luminal signal throughout the arterial tree — repeat with MSDE preparation

Pulsation artefacts from cardiac motion of intracranial arteries

The basilar artery and carotid siphon pulsate in synchrony with the cardiac cycle. At high resolution (0.5 mm), this pulsation produces blurring and ghost artefacts.

• Physical cause: cardiac-related vessel wall pulsation displaces the wall position by 0.2–0.5 mm per cardiac cycle
• Appearance: wall blurring; apparent wall thickening from motion blur; ghost artefacts in the phase direction
• Reduction: cardiac gating (peripheral pulse unit or ECG) synchronises k-space acquisition to a quiescent cardiac phase; adds complexity but substantially improves basilar and carotid VWI quality
• Practical note: most clinical 3D VWI protocols accept mild pulsation blurring for the practical benefit of free-running (non-gated) acquisition; cardiac gating is reserved for single-vessel targeted acquisitions

Motion artefact from patient movement: the 5–10 minute 3D VWI acquisition at sub-millimetre resolution is highly motion-sensitive — any head movement degrades the entire 3D dataset. Reduction: firm head immobilisation; patient instruction; reduce acquisition time using CS acceleration (Section 5.2); consider navigator-based prospective motion correction (research/advanced clinical).

Susceptibility artefacts from dental metalwork: at 3T, posterior upper dental metalwork produces susceptibility artefacts extending into the MCA territory — the same limitation documented in the paranasal sinuses and skull base protocols. Reduction: 1.5T for patients with extensive dental metalwork when MCA VWI is the primary question (noting the reduced sensitivity for thin-wall arteriopathies at 1.5T).

Partial volume artefact from small vessel size: when the vessel diameter is small relative to the voxel size, the wall signal is partially averaged with luminal blood signal and perivascular CSF, producing apparent wall thickening when the true wall is normal. Reduction: highest achievable spatial resolution — isotropic ≤ 0.5 mm at 3T, 0.3–0.4 mm for targeted acquisitions; use of vessel wall enhancement (rather than thickness alone) as the primary diagnostic criterion for pathology.

5.2 Protocol Efficiency and Throughput

A complete intracranial VWI protocol — pre-contrast 3D black-blood T1 + 3D TOF MRA + post-contrast 3D black-blood T1 + DWI + T2 + FLAIR — requires approximately 45–60 minutes at 3T. This is the full diagnostic session time and is appropriate when VWI is the primary clinical question. When VWI is added to a standard brain MRI protocol, the additional VWI-specific components (pre-contrast + post-contrast 3D black-blood) add approximately 15–20 minutes.

Compressed sensing (CS) acceleration for VWI: CS-accelerated 3D black-blood sequences (available on Siemens SPACE, Philips VISTA-BB, GE CUBE) can reduce acquisition time by 2–3× at maintained resolution and SNR. CS-accelerated whole-brain VWI at 0.5 mm isotropic in 5–6 minutes (vs 10–12 minutes without CS) is now standard at advanced VWI centres. This acceleration makes whole-brain VWI clinically feasible within a standard MRI slot.

5.3 Field Strength Considerations

3T is the minimum clinical standard for intracranial VWI. At 3T: in-plane resolution of 0.5 mm isotropic is achievable within a 5–10 minute acquisition at adequate SNR; MSDE-prepared black-blood suppression is more complete at 3T (longer tissue T1 → less incomplete recovery); wall enhancement detection is reliable for gadolinium-enhancing lesions (vasculitis, vulnerable ICAD plaque).

1.5T VWI: in-plane resolution is limited to 0.7–1.0 mm at acceptable SNR within clinical scan time. At this resolution, the wall of normal intracranial arteries (0.2–0.5 mm thick) is below or at the resolution limit, making normal wall detection unreliable and wall thickness measurements artefactually elevated from partial volume. Expert consensus [1] recommends 3T as the minimum standard; 1.5T VWI is acceptable only for large vessel assessment (MCA M1, basilar) and when 3T is unavailable.

7T VWI: the higher intrinsic SNR at 7T enables 0.3–0.4 mm isotropic resolution, resolving the intracranial arterial wall at near-histological detail. This enables visualisation of the individual layers (intima, media, adventitia) of large intracranial arteries and detection of very subtle wall changes. 7T VWI has been validated in research settings for vasculitis, ICAD plaque characterisation, and aneurysm wall assessment. Commercial 7T VWI protocols exist but are not yet standardised across centres. The B1+ inhomogeneity limitation of 7T (affecting skull base arteries disproportionately) and the pTX requirement reduce universal applicability.

SAR at 3T: the long 3D black-blood TSE sequences with MSDE preparation generate substantial SAR. At 3T with the variable flip angle TSE readout, SAR monitoring is mandatory. The MSDE preparation adds additional RF pulses per TR. When VWI is combined with other high-SAR sequences (FLAIR, 3D T2, fat-saturated sequences) in the same session, TR extension or sequence reordering may be required.

6. Contrast Use Principles Specific to VWI

6.1 Non-Contrast VWI — Sufficient For

Non-contrast 3D black-blood T1 is diagnostically adequate for: intramural haematoma detection in dissection (T1-bright crescent without gadolinium); ICAD plaque lipid core identification (T1-bright pre-contrast); assessment of wall morphology and thickness (wall thinning vs thickening; eccentricity vs concentric pattern); initial survey when gadolinium is contraindicated (renal impairment, allergy). Non-contrast VWI does not differentiate active inflammation (enhancing) from quiescent fibrotic wall change (non-enhancing) — both may show wall thickening without gadolinium.

6.2 Gadolinium — Indicated for Most Clinical VWI Indications

Post-contrast 3D black-blood T1 is required for: vasculitis (primary or secondary) — the enhancement pattern is the most important diagnostic criterion; uniform, concentric, circumferential gadolinium enhancement is the hallmark of intracranial vasculitis and cannot be demonstrated without contrast, since non-contrast VWI shows wall thickening but cannot confirm the active inflammatory component; ICAD vulnerable plaque — gadolinium enhancement of the plaque fibrous cap and neovascular core correlates with plaque vulnerability and recent ischaemic events, and eccentric plaque enhancement is the primary VWI criterion for culprit ICAD in stroke [1,2]; intracranial aneurysm wall assessment — aneurysm wall enhancement (AWE), the post-contrast signal increase at the aneurysm dome/neck, is the primary VWI biomarker for unstable aneurysm biology and requires post-contrast imaging; leptomeningeal and perianeurysmal enhancement — contrast is required to detect the perivascular inflammatory pattern in PACNS and the perianeurysmal enhancement (PAE) associated with ruptured or symptomatic aneurysms.

6.3 Post-Contrast Acquisition Timing

Immediate post-injection (3–5 minutes): standard for vasculitis and ICAD plaque — gadolinium enhancement of the active inflammatory wall components is maximal early.

Delayed (5–15 minutes post-injection): for aneurysm wall enhancement assessment, some groups advocate slightly delayed imaging to allow gadolinium to distribute into the wall adventitia and the fibrous inflammatory tissue, improving the conspicuity of wall enhancement. There is no consensus on the optimal timing, and this remains institution-dependent practice. Document the injection-to-imaging delay in the report.

7. Reporting Essentials

7.1 Interpretation Framework — The VWI Diagnostic Axes

Primary question: is there focal or diffuse arterial wall pathology? Where? Which arteries?

Wall thickening assessment: normal intracranial wall thickness 0.2–0.5 mm (vessel-dependent); pathological thickening — wall thickness > 1 mm is reliably abnormal in most intracranial arteries; pattern — eccentric (one side of the wall thicker than the other) vs concentric (circumferential, symmetric).

Enhancement pattern — the diagnostic discriminator:

The culprit lesion concept: in stroke evaluation, the VWI "culprit" is the artery-wall abnormality in the vessel whose territory matches the DWI ischaemic lesion. A VWI-positive segment in an artery supplying the DWI territory is the probable stroke cause. A VWI-positive segment in a remote artery is an incidental finding or a concurrent pathology.

Positive vs negative remodelling: positive remodelling — the outer vessel diameter is preserved or enlarged despite mural plaque, the artery expands outward to accommodate plaque growth, associated with ICAD, often producing little or no lumen narrowing on MRA; negative remodelling — the outer vessel diameter is reduced by plaque, lumen narrowing is proportional to wall thickening, less specific.

7.2 Mandatory Reporting Checklist

Technique documentation: field strength (3T / 7T / 1.5T, note if suboptimal); black-blood preparation (MSDE / DIR / combined, specify sequence name); voxel size (must be ≤ 0.6 mm isotropic for standard intracranial VWI, document if larger); gadolinium agent, dose, injection-to-imaging delay; MRA type (TOF / CE-MRA, for lumen reference); DWI included / not included.

Coverage assessment: Circle of Willis fully covered bilaterally; basilar artery full length assessed; both MCAs (M1 ± M2) assessed; both ICAs (cavernous + supraclinoid) assessed; vertebral V4 segments bilaterally assessed.

Vessel-by-vessel assessment (positive findings): for each artery with a finding, document — artery (side + segment); lumen stenosis grade (WASID or % reduction) from MRA; wall thickening (focal / segmental / diffuse; thickness measurement in mm); eccentricity (eccentric / concentric); remodelling (positive / negative / unable to assess); pre-contrast T1 signal (isointense / T1-bright); post-contrast enhancement (absent / mild / moderate / marked; pattern); DWI correlation (corresponding territory DWI positive / negative).

Culprit lesion conclusion: VWI finding consistent with culprit lesion for current DWI territory / incidental finding / cannot determine.

7.3 Structured Reporting Template

Indication: cryptogenic stroke / symptomatic intracranial stenosis characterisation / vasculitis / aneurysm risk stratification / other.

Technique: 3T head coil; 3D black-blood T1 [sequence name, vendor]; voxel size [mm] isotropic; [gadolinium agent, dose] at [time]; injection-to-imaging interval [minutes]; 3D TOF MRA; DWI included.

Comparison: prior VWI [date]; prior MRA [date]; prior DWI [date].

Findings — systematic vessel assessment: [for each positive finding — artery, segment, wall thickening, eccentricity, remodelling, pre-contrast T1, post-contrast enhancement, DWI territory correlation]. [Negative vessels: "No abnormal wall thickening or enhancement identified in the (right/left ICA, MCA, ACA, PCA, basilar artery, vertebral arteries)."]

Impression: [Primary diagnosis: ICAD / vasculitis / dissection / normal / incidental non-culprit]; [culprit designation for stroke indication]; [aneurysm wall instability assessment if relevant].

Limitations: [resolution if > 0.6 mm]; [motion]; [susceptibility from dental metalwork — region affected]; [residual intraluminal signal — arteries affected].

7.4 Incidental Findings — Clinical Decision Framework

Usually benign: mild diffuse wall thickening (< 0.5 mm additional) in older patients without symptoms (likely early atherosclerosis without active plaque); smooth uniform non-enhancing wall thickening in vessels remote from the symptomatic territory.

Requires clinical correlation: incidental enhancing wall segment in an artery without a corresponding DWI lesion — may represent non-culprit ICAD or subclinical vasculitis; recommend neurology review and follow-up VWI.

Urgent communication: unexpected intracranial aneurysm with wall enhancement in a patient not known to have aneurysm; leptomeningeal enhancement pattern suggesting PACNS or infectious meningitis; bilateral symmetric vasculitis pattern suggesting secondary cause requiring systemic investigation.

8. MRI Technologist Pearls

8.1 Sequence Order Logic

Below is the typical ordering for the common case of a stroke-indication examination, where the companion brain-protocol sequences (Section 4.2) are included alongside the VWI-specific core (Section 4.1). For a non-stroke indication (e.g. isolated aneurysm-wall assessment), steps 1–3 are not required by VWI itself and may be omitted per the requesting clinician.

1. DWI + ADC ← first, when included; ischaemic lesion localisation; any brain emergencies identified (companion sequence, Section 4.2)
2. T2 brain axial ← when included (companion sequence, Section 4.2)
3. FLAIR ← when included (companion sequence, Section 4.2)
4. 3D TOF MRA ← pre-contrast; lumen reference (VWI-specific core, Section 4.1)
5. Pre-contrast 3D black-blood T1 ← before gadolinium; establishes T1-bright wall content reference (VWI-specific core, Section 4.1)
6. Gadolinium injection
7. Post-contrast 3D black-blood T1 ← matched geometry to pre-contrast; 3–5 min post-injection (VWI-specific core, Section 4.1)
8. SWI ← last (if included)

The pre-contrast black-blood T1 must be acquired before gadolinium injection to enable subtraction and to avoid confounding of pre-existing T1-bright content with true enhancement — this requirement applies regardless of whether the companion brain sequences are included.

8.2 Positioning Tricks

Verify the Circle of Willis coverage before starting: on the sagittal localiser, check that the 3D black-blood slab covers the full Circle of Willis, from the carotid siphon (inferiorly) to the MCA/ACA bifurcations (superiorly). If the slab is too short, extend inferiorly.

Verify blood suppression on the first acquisition before proceeding: after acquiring the pre-contrast 3D black-blood T1, scroll through the axial reformats and confirm that the major arteries (basilar, ICA, MCA) appear dark (suppressed). If significant residual luminal signal is present, troubleshoot before injecting gadolinium — a poor pre-contrast acquisition will not improve with contrast.

Identical geometry is non-negotiable for pre/post subtraction: when setting up the post-contrast 3D black-blood, use the "copy geometry" function to import the exact slab position, FOV, and voxel size from the pre-contrast acquisition. Do not adjust any geometric parameter between pre and post.

8.3 Fast Salvage Protocol

Approximately 15 minutes — the minimum clinically useful VWI dataset.

8.4 Common Avoidable Errors

9. Quality Control Checklist

• Field strength: 3T / 7T (1.5T: document as substandard for thin-wall arteriopathy)
• Voxel size: ≤ 0.6 mm isotropic — verified before reporting
• Black-blood preparation active: MSDE / DIR — documented in report
• Circle of Willis coverage: complete bilaterally (ICA, MCA, ACA, PCA, basilar, VA bilateral)
• Blood suppression quality: major arteries appear dark; no extensive residual luminal signal
• Pre-contrast 3D black-blood T1: acquired before gadolinium injection
• Post-contrast 3D black-blood T1: identical geometry to pre-contrast
• Subtraction image (post minus pre) generated and reviewed
• 3D TOF MRA: acquired and co-registered for lumen reference
• DWI (companion brain-protocol sequence, Section 4.2): included and ischaemic territory documented — required only for the stroke-indication examination, not universally for every VWI study
• Perpendicular cross-sectional reformats generated at each abnormal segment
• Gadolinium agent, dose, and injection-to-imaging delay documented in report
• Motion artefact assessed: absent / mild / severe (document if severe)
• Residual luminal signal: absent / present at [arteries] — noted in report

10. Advanced Technical Parameters

10.1 3D Black-Blood T1 — Technical Architecture

The MSDE Preparation — Why It Replaced DIR for Intracranial VWI

MSDE (Motion Sensitised Driven Equilibrium) uses a 90° excitation pulse followed by a bipolar gradient pair and a 90° flip-back pulse. Stationary tissue spins undergo the excitation, accumulate a velocity-dependent phase from the bipolar gradient, and are flipped back to the longitudinal axis, maintaining their T1-weighted signal for imaging. Moving (flowing) blood spins accumulate an additional phase from their velocity-dependent displacement between the two gradient lobes and are not coherently returned to the longitudinal axis — their signal is dephased to near-zero before readout.

Advantages of MSDE over DIR: works for all flow directions simultaneously (DIR only works efficiently for through-plane flow); more complete suppression of slow flow (in aneurysm sacs, recirculation zones) than DIR; no TI timing requirement (DIR must be timed for a specific flow velocity); compatible with 3D acquisitions covering multiple flow directions simultaneously.

Limitation: MSDE is sensitive to patient motion (the velocity-encoding gradient can dephase slowly-moving tissue near the vessel wall, producing a thin rim of reduced wall signal adjacent to the lumen — the "black wall artefact" or MSDE wall erosion). This effect is minimised by carefully tuning the MSDE velocity sensitivity (VENC, typically 2–4 cm/s for intracranial VWI).

Key Parameters

Vendor implementations: Siemens — SPACE with MSDE preparation; T1 SNAP (combined T1-black-blood and susceptibility); Philips — VISTA-BB (VISTA with black-blood preparation); GE — CUBE with MSDE preparation; Canon — isoFSE BB equivalent.

10.2 Enhancement Grading Schemes

Published VWI reporting schemes for wall enhancement include the ASNR consensus qualitative grading [1]: 0 — no enhancement; 1 — mild enhancement (less than adjacent pituitary infundibulum); 2 — marked enhancement (equal to or greater than adjacent pituitary infundibulum). The pituitary infundibulum is used as an internal enhancement reference because it enhances consistently and is visible on standard brain MRI in the same plane as the intracranial arteries.

Contrast ratio (semi-quantitative): CR = (Signal_wall,post − Signal_wall,pre) / Signal_wall,pre. A CR > 15% is often used as the threshold for significant wall enhancement in published studies, though this has not been universally validated.

11. Evidence Gaps and Ongoing Debate

Standardisation of VWI acquisition parameters: despite the ASNR consensus [1], significant inter-centre variation exists in voxel size, black-blood preparation, gadolinium dose, and injection-to-imaging timing. This variability limits multi-centre comparison and meta-analysis. No regulatory mandate or accreditation requirement for specific VWI parameters exists at the time of writing.

Aneurysm wall enhancement and rupture risk — prospective validation: most evidence linking AWE to aneurysm rupture risk comes from retrospective studies comparing ruptured and unruptured aneurysms cross-sectionally [3]. Prospective longitudinal studies demonstrating that AWE predicts future rupture — independent of size and other morphological criteria — are limited in size and duration. The clinical implementation of AWE as a treatment decision criterion therefore remains evidence-limited.

Optimal gadolinium dose and timing for VWI: standard dose (0.1 mmol/kg) is widely used. Some groups report improved wall enhancement detection with double dose (0.2 mmol/kg), particularly for thin-walled small vessel vasculitis. No prospective comparative trial has established the optimal dose for specific VWI indications.

Artificial intelligence for automated vessel wall segmentation and plaque characterisation: AI-based automated wall segmentation from 3D VWI has been developed in research settings and has shown accuracy approaching expert readers for wall thickness measurement and enhancement detection. No clinically validated, regulatory-cleared AI VWI analysis tool exists at the time of writing.

7T VWI — clinical standardisation: 7T VWI enables near-histological wall resolution and has been validated for multiple intracranial arteriopathies in research settings. Standardised clinical 7T VWI protocols, the clinical indications for 7T vs 3T VWI, and the role of pTX in achieving uniform 7T black-blood suppression are not yet established.

12. Evidence-Based References

A. Guidelines / Consensus / Society Recommendations

B. Systematic Reviews / Meta-analyses

C. Important Prospective / Original Studies

D. Technical MRI Papers

E. Landmark Historical References

End of document — MRI Vessel Wall Imaging Generic Standard Protocol — MRIninja v1.0 — September 2026